Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00309842 | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases | ||
| NCT01009437 | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer | ||
| NCT00303667 | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | ||
| NCT00357565 | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT00775931 | Allogeneic Transplantation For Severe Osteopetrosis | ||
| NCT00428194 | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer | ||
| NCT04105270 | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial | ||
| NCT02666105 | Exemestane in Post-Menopausal Women With NSCLC | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT06692426 | Trial of Cell Based Therapy for DMD | ||
| NCT00003926 | Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | ||
| NCT00095160 | Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
| NCT00265863 | Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT01639456 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission | ||
| NCT03316456 | Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction | ||
| NCT00625729 | Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT03651037 | Physical Activity Platform to Improve Bone Health in Cancer Survivors | ||
| NCT00167180 | Post Transplant Donor Lymphocyte Infusion | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT00392782 | Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease | ||
| NCT00365547 | Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT03609203 | Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training | ||
| NCT00356941 | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC | ||
| NCT00617188 | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT00176852 | Stem Cell Transplant for Hemoglobinopathy | ||
| NCT02991898 | Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies | ||
| NCT00869323 | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders | ||
| NCT00258362 | Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | ||
| NCT01962636 | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | ||
| NCT01215981 | Influenza Vaccine Post Allogeneic Transplant | ||
| NCT01173016 | Administration of IV Laronidase Post Bone Marrow Transplant in Hurler | ||
| NCT07008638 | Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML) | ||
| NCT00005985 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | ||
| NCT00376519 | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases | ||
| NCT00478244 | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa | ||
| NCT01572636 | Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome |
